Euro-BioImaging update regarding COVID-19


April 7, 2020
COVID-19

Following closely the Covid-19 situation, Euro-BioImaging asks everyone involved, including Euro-BioImaging users, to align with the recommendations of their relevant national health departments.

Euro-BioImaging will process the online submission of new user proposals as before, but flexibility needs to be applied when it comes to scheduling a physical user visit until available information on the European situation allows again for reliable and safe travel planning. Euro-BioImaging is also looking into the implementation of additional activities and services that do not require physical traveling and ways to keep a constructive momentum during these exceptional times.

Regarding any upcoming meetings, Euro-BioImaging will continue following the general development and act in accordance.


More news from Euro-BioImaging

The Euro-BioImaging SAB members and Directorate at EMBL Heidelberg, October 2024. Photo by Kinga Lubowiecka, EMBL/Photolab. 

October 22, 2024

Meeting with our SAB in Heidelberg

The Euro-BioImaging Hub team was delighted to meet in person with our Scientific Advisory Board (SAB) at EMBL Heidelberg October 8-9. The Euro-BioImaging Scientific…

Illuminate_hero

October 21, 2024

ILLUMINATE brings together private-public partners to advance novel theranostics-based cancer treatments

Euro-BioImaging is thrilled to be part of ILLUMINATE (Increasing Lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership…

Visual Computing Award

October 18, 2024

Submit your image data for the VRVis Visual Computing Award 2025

VRVis Zentrum für Virtual Reality und Visualisierung is Austria’s leading research center in the field of visual computing and a founding member of Euro-BioImaging’s…